The results of the validation of the GEO dataset showed that compared with normal samples, the mRNA expression level of CCL20 and RPL17 in COPD samples were significantly increased (p < 0.05), as shown in Figure 4B. The gene discussed is CCL20; the disease is chronic obstructive pulmonary disease.